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ABSTRACT
            The present study was carried out to evaluate the antibacterial activity of bark, stem, root, leaf and fruit
extracts from Terminalia arjuna on selected Gram positive and Gram negative bacterial strains. Aqueous extracts
were used to evaluate the antibacterial activity. Phytochemical extracts from different parts of the plant exhibited
significant anti-bacterial activity against tested microbial strains; however, inhibitory activities of the extracts were
plant part and test organism dependent. Phytochemical extracts limited the growth of both Gram-positive and Gram-
negative bacterial species tested however, Micrococcus luteus was less sensitive to the aqueous extracts. The results
show that antimicrobial activity of phytochemical extracts of T. arjuna were concentration dependent (1.0 mg/disc
and 5.0 mg/disc) on the bacterial strains tested. Further, the results depicts that bark extracts of T. arjuna could be
used as a potential source of antimicrobial agents against the bacterial strains tested.
KEY WORDS: Terminalia arjuna; Medicinal Plant; Antibacterial Activity; Disc Diffusion Assay; Bark/ Stem,
Leaf/ Fruit extracts.
 
INTRODUCTION
            In India, medicinal plants form the backbone of several indigenous traditional systems of medicine.
Pharmacological studies have acknowledged the value of medicinal plants as potential source of bioactive
compounds (Prusti et al., 2008). Phytochemicals from medicinal plants serve as lead compounds in drug discovery
and design (Ebi and Ofoefule, 2000). Medicinal plants are rich source of novel drugs that forms the ingredients in
traditional systems of medicine, modern medicines, nutraceuticals, food supplements, folk medicines, pharmaceutical
intermediates, bioactive principles and lead compounds in synthetic drugs (Ncube, 2008).
            WHO, report depicts that more than 80% of world’s population rely on plants based products to meet their
health care needs. Nearly, 25 to 45% of modern prescriptions contain plant derived lead molecules as a basic source
in drug formulations. The value of plant based prescribed drugs in 1990 was estimated at $15.5 billon which has
been on the raise since then. Furthermore, about 42% of 25 top selling drugs marketed world wide are either directly
obtained from natural sources or entities derived from plant products (Ramya et al., 2008). Overexploitation of
selected medicinal plant species has led to significant reduction in number of plants in the wild. Nevertheless,
ruthless hunting has resulted in inclusion of their name in the red data book (Ahmedullah and Nayar 1999).
            In recent years, multiple drug resistance in both human and plant pathogens has been developed due to
indiscriminate use of synthetic drugs especially in the developing countries (Hart and Karriuri, 1998). Thus, a
diverse arsenal of new antibacterial agents is urgently needed to combat the diminishing efficacy of existing
antibiotics (Chopra et al., 1997). To this emerging problem, phytochemicals obtained from medicinal plants are the
sole remedy. This drives the need to screen medicinal plants for novel bioactive compounds as plant based drugs are
biodegradable, safe and have fewer side effects (Ramya et al., 2008). The demanding healthcare needs and the
ability to cure disease with fewer side effects are the driving force behind the resurge of interest world over in the
hunt for elite indigenous germplasm of pharmacological prominence.
        Terminalia arjuna Wight & Arn., (family: Combretaceae) popularly known as ‘Arjuna’ (Dwivedi and Udupa,
1989) is a deciduous tree common throughout India. The tree normally grows to a height of 60-90 feet. Traditionally,
it has been used as a cardiotonic and has been indicated for derangement of three humours viz., vata, pitta and kapha
in Ayurveda. Bark of T. arjuna has been widely used in traditional system of medicine for a variety of purposes.
Ancient Indian physicians used the powdered bark of T. arjuna for alleviating "hritshool" (angina) and other
cardiovascular conditions (Dwivedi, 2007). Bark powder used as astringent and diuretic finds mention in works of
Carak. Bark of T. arjuna has been attributed to possess cardio protective properties as described by Vagbhatta, in
‘Astang Hridayam’ as early as 500 CE (Dwivedi, 2007). As of now, in many of the traditional medicine, alcoholic
extract of bark (asava) is administered with butter (ghrita) or boiled milk (kshirpak) (Warrier et al., 1996).
            Phytochemical extracts from Terminalia species have been known for their antioxidant and antimicrobial
properties. They are used in the management of cardiovascular diseases, myocardial infarction, degenerative
neurological diseases, cancer, amyloidosis, acute pancreatitis, arthritis, atherosclerosis, inflammatory bowel disease,
diabetes, senile dementia, retinal degeneration and senile cataract particularly in humans owing to their antioxidation
potential (Dwivedi, 2007). Further, it has been reported that bark of T. arjuna exhibits antioxidant activity only in
direct aqueous extract as determined in vitro by DPPH radical scavenging and deoxyribose damage protection assay
and on lipid peroxidation. Ram et al. (1997) reported that ethanolic extract of T. arjuna bark at a concentration of
100-500mg/kg significantly reduces total and LDL cholesterol levels in hypercholesterolaemic rabbits. Similarly, it
has been reported that bark aqueous extract of T. arjuna at a concentration of 50 mg/kg prevented the rise in liver
injury enzymes, SGPT, ALP and TBARS and increased the levels of SOD, CAT, and GSH and the results were
comparable to vitamin C group mice (Manna et al., 2006).
            Recently, Devi et al. (2007), evaluated the effect of methanolic extract of T. arjuna on diclofenac sodium
induced gastric ulcer in experimental rats and concluded that extracts of T. arjuna act as gastroprotective agent due
to its free radical scavenging activity and cytoprotective nature. Studies have shown that bark of T. arjuna contains
glycosides, flavonoids, tannins and minerals. Flavonoids have been reported to exert antioxidant, anti-inflammatory
and lipid lowering effects while glycosides are cardiotonic, thus making T. arjuna unique amongst the medicinal
plants (Dwivedi, 2007). Major phytochemicals present in different parts of T. arjuna is listed in Table 1 (Dwivedi,
2007).
            However, only little work has been carried out with the phytochemical extracts as far as the antimicrobial an
activity is concerned. Valsaraj et al. (1997) reviewed the antibacterial activity of some of the Indian medicinal
plants. In a study, Perumalsamy et al., (1998) showed that aqueous extracts bark of T. arjuna holds significant
antibacterial activity against Escherichia coli, Klebsiella aerogenes, Proteus vulgaris, and Pseudomonas aerogenes.
Recently, Singh et al., (2008) indicated the presence of antibacterial principles in the bark of T. arjuna with arjunetin
particularly exhibiting selectively higher activity against S. epidermidis. However, not much of work has been done
on the antibacterial activity of root, leaves and fruits of T. arjuna. In the present work, we describe antibacterial
activity of aqueous extracts of bark, root, leaves and fruits of T. arjuna.
 
MATERIALS AND METHODS
Collection of Plant Material
            Mature bark, root, leaves and fruits of T. arjuna were collected from the wild in Vellore District, Tamilnadu,
India during Apr – Jun 2008. The Flora of Presidency of Madras (Gamble, 1935) and The Flora of Tamil Nadu
Carnatic (Matthew, 1983) were used for identification and authentication of the plants. Collected material was
washed thoroughly in running tap water, rinsed in distilled water and shade dried in open air and ground to powder.
 
Preparation of Phytochemical Extracts
            The powder was extracted by maceration in double distilled water. The plant extracts were concentrated using
rotary evaporator (Buchi, Switzerland) and stored at 4  until used in the assay.
 
Test Organisms
            Eight strains of Gram-positive bacteria - Micrococcus glutamicus, Lactobacillus bulgaris, Streptococcus
faecalis, Staphylococcus aureus, Bacillus stearothermophilus, Staphylococcus pyogenes, Micrococcus luteus,
Bacillus cereus and two strains of Gram negative bacteria - Escherichia coli and Pseudomonas aeruginosa were
used to evaluate the antibacterial activity (Table 2). All bacterial cultures were maintained in NA slants/ plates;
stored at 4  and periodically sub-cultured.
 
Antimicrobial Activity Test
            Antimicrobial activity was tested using a modified disc diffusion assay (DDA) method originally described
by Bauer (1966) and Ncube et al (2008).  Plant extracts were dissolved in 20% DMSO treated water. The inoculums
for each microorganism were prepared from broth cultures (105 CFU/ml). A loop of culture from the NA slant stock
was cultured in LB medium overnight and spread with a sterile swab into Petri-plates. Sterile disc (6 mm dia, Hi-
media, Mumbai, India) impregnated with the plant extracts (1.0 mg/disc and 5.0 mg/disc) were placed on the
cultured plates and incubated for 24 h at 37 . The solvent loaded disc without extracts in it served as control in the
study. The results were recorded by measuring the zones of growth inhibition. Clear inhibition zones around discs
indicated the presence of antimicrobial activity. All data on antimicrobial activity were average of triplicate.
 
RESULTS AND DISCUSSION
            Plants are known to have beneficial therapeutic effects documented in Traditional Indian System of
Medicine. Though bioactive products of Arjuna have been used in treatment of various aliments since time
immemorial, role of phytochemical in inhibition of growth of microorganisms has gained less prominence
(Sasidharan et al., 1998). In the present study, aqueous extracts of bark/ stem, root, leaves and fruits of T. arjuna
were tested against selected Gram positive and Gram negative bacterial species (Table 3). Different extracts of T.
arjuna exhibited significant anti-bacterial activity against all test organisms. Bark extracts limited the growth of both
Gram-positive and Gram-negative bacterial species tested. However, inhibitory role of leaf extracts was organism
dependent. Aqueous extracts of leaves and the fruits were active towards the Gram negative strains and less active
towards the Gram positive stains used in the study (Table 3). Among the different microorganisms tested maximum
inhibition was found in E. coli followed by P. aeruginosa, B. cereus, B. subtilis and L. bulgaris. However, M.
glutamicus and M. luteus remained less sensitive to aqueous extracts of T. arjuna. Of the different extracts tested,
bark extract exhibited significantly higher activity towards all the strains expect M. glutamicus. However, leaf and
fruit extracts were not active towards any of the Gram positive strains used in the study.
 
CONCLUSION
            Arjuna, the versatile traditional medicinal plant of India, is the rich source of bioactive compounds with
diverse chemical structure. As of now, little work has been done on the biological activity and plausible medicinal
applications of the phytochemical compounds and hence extensive investigation is needed to exploit the bioactive
principles of Arjuna for therapeutic utility. In the present study antibacterial activity of T. arjuna extracts towards
drug resistant/ clinically significant microbes has been investigated. Further investigations may lead to development
of new antibiotic (s) of high potency.
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Table 1. Major chemical constituent in different parts of T. arjuna.
 
Compound Stem/ bark Root Leaf/fruit
Triterpenoids Arjunin, Arjunic acid, Arjunolic
acid, Arjungenin, Terminic acid
Arjunic acid,
Arjunolic acid,
Oleanolic acid, 
Terminic acid
 
Glycosides Arjunetin, Arjunaphthanoloside,
Arjunoside I, II and Terminoside
A
Arjunoside I-IV
Glucopyranoside
 
Sitosterol Sitosterol Sitosterol  
Flavonoids Arjunolone, Arjunone , Bicalein
Luteolin, Gallic acid, Ethyl
gallate 
Kempferol, Proanthocyanidins,
Quercetin, Pelorgonidin,
 Luteolin
Tannins Pyrocatechols, Casuarinin,
Casurin,
Punicallin, Punicalagin,
Castalagin,
Terchebulin, Terflavin C,
  
Trace elements Calcium, Aluminium,
Magnesium,
Silica, Zinc, Copper
  
(Source:  Dwivedi S (2007), Journal of Ethnopharmacology, 114:114-129).
 
 
Table 2. Bacterial strains used in the present study.
 
S. No Bacterial strain Gram (+/-)
1 Escherichia coli -
2 Pseudomonas aeruginosa -
3 Bacillus cereus +
4 Bacillus subtilis +
5 Lactobacillus bulgaris +
6 Micrococcus glutamicus +
7 Micrococcus luteus +
8 Staphylococcus aureus +
9 Staphylococcus pyogenes +
10 Streptococcus faecalis +
 
 
Table 3. Anti-microbial activity of T. arjuna aqueous extracts.
 
Organism Stem/ bark Root Leaf/ fruit
1 mg/ml 5 mg/ml 1 mg/ml 5 mg/ml 1 mg/ml 5 mg/ml
Escherichia coli + ++ + ++ + ++
Pseudomonas aeruginosa + ++ + + + ++
Bacillus cereus + ++ + + - -
Bacillus subtilis + ++ + + - -
Lactobacillus bulgaris + ++ + + - -
Micrococcus glutamicus - - - - - -
Micrococcus luteus - + - - - -
Staphylococcus aureus - + - + - -
Staphylococcus pyogenes - + - + - -
Streptococcus faecalis + ++ + + - -
(Growth analysis: ++ =more; + =less; - = no)
 
 
